Specificity of 17β-oestradiol and benzo[α]pyrene oxidation by polymorphic human cytochrome P4501B1 variants substituted at residues 48, 119 and 432

References

• AGARWAL, R., COFFING, S. L., BAIRD, W. M., KISELYOV, A. S., HARVEY, R. G. and DIPPLE, A., 1997, Metabolic activation of benzo[g]chrysene in the human mammary carcinoma cell line MCF-7. Cancer Research, 57, 415–419.
   PubMed Web of Science ®Google Scholar
• BAILEY, L. R., Room, N., DuPow, W. D. and PARL, F. F., 1998, Association of cytochrome P4501B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Research, 58, 5038–5041.
   PubMed Web of Science ®Google Scholar
• BEHAN', B. A., LEWIS, R. A., TOMEY, K. F., ANDERSON, K. L., DUEKER, D. K., JAEAE, M., ASTLE, W. F., OTTERUD, B., LEPPERT, M. and LUFSKI, J. R., 1998, Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. American Journal of Human Genetics, 62, 325–333.
   PubMed Web of Science ®Google Scholar
• BUTERS, J. T. M., SAKAI, S., RICHTER, T., PINEAU, T., ALEXANDER, D. L., SAVAS, U., DOEHMER, J., WARD, J. M., JEFCOATE, C. R. and GONZALEZ, F. J., 1999, Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proceedings of National Academy of Sciences, USA, 96, 1977–1982.
   Google Scholar
• CROFTS, F. G., STRICKLAND, P. T., HAYES, C. L. and SUTTER, T. R., 1997, Metabolism of 2-amino-l-methy1-6-phenylimidazo[4,5-b]pyridine (PhIP) by human cytochrome P4501B1. Carcinogenesis, 18, 1793–1798.
   Web of Science ®Google Scholar
• GELBOIN, H. V., 1980, Benzo[a]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiology Reviews, 60, 1107–1166.
   PubMed Web of Science ®Google Scholar
• GILLAM, E., BABA, T., KIM, B.-R., OHMORI, S. and GUENGERICH, F. P., 1993, Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Archives of Biochemistry and Biophysics, 305, 123–131.
   Google Scholar
• GONZALEZ, F. J., 1989, The molecular biology of cytochrome P450s. Pharmacological Reviews, 40, 243–288.
   Web of Science ®Google Scholar
• GUENGERICH, F. P. and SHIMADA, T., 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology, 4, 391–407.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P. and SHIMADA, T., 1998, Activation of procarcinogens by human cytochrome P450 enzymes. Mutation Research, 400, 201–213.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., WANG, P. and DAVIDSON, N. K., 1982, Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits and humans using imrnunochemical staining coupled with sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Biochemistry, 21, 1698–1706.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., WANG, P. W., MITCHELL, M. B. and MASON, P. S., 1979, Rat and human liver microsomal epoxide hydratase. Purification and evidence for the existence of multiple forms. Journal of Biological Chemistry, 254, 12248–12254.
   PubMed Web of Science ®Google Scholar
• HANNA, I. H., DAWLING, S., Room, N., GUENGERICH, F. P. and PARL, F. F., 2000, Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in oestrogen hydroxylation activity. Cancer Research, 60, 3440–3444.
   PubMed Web of Science ®Google Scholar
• INouE, K., ASAO, T. and SHIMADA, T., 1999, Ethnic-related differences in frequency distribution of genetic polymorphisms in CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations. Xenobiotica, 30, 285–295.
   Web of Science ®Google Scholar
• JOHNSON, W. W., YAMAZAKI, H., SHIMADA, T., UENG, Y.-F. and GUENGERICH, F. P., 1997, Afiatoxin Bi 8,9-epoxide hydrolysis in the presence of rat and human epoxide hydrolase. Chemical Research in Toxicology, 10, 672–676.
   Google Scholar
• KABAT, G. C., CHANG, C. J., SPARANO, J. A., SEFICOVIC, D. W., Hu, X. P., KHALIL, A., ROSENBLATT, R. and BRADLOW, H. L., 1997, Urinary oestrogen metabolites and breast cancer: a case-control study. Cancer Epidemiology, Biomarkers and Prevention, 6, 505–509.
   PubMed Web of Science ®Google Scholar
• Li, D. N., SEIDEL, A., PRITCHARD, M. P., WOLF, C. R. and FRIEDBERG, T., 2000, Polymorphisms in P450 CYP1B1 affect the conversion of oestradiol to the potentially carcinogenic metabolite 4-hydroxyoestradiol. Pharmacogenetics, 10, 343–353.
   PubMedGoogle Scholar
• LEI, J. G., Ricci, M. J., JEFCOATE, C. R., HANNIGAN, E. V., HOKANSON, J. A. and Zuu, B. T., 1995, 4-Hydroxylation of oestradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proceedings of National Academy of Sciences, USA, 92, 9220–9224.
   PubMed Web of Science ®Google Scholar
• LiEuLE, J. G. and Rocci, M. J., 1996, 4-Hydroxylation of oestrogens as marker of human mammary tumors. Proceedings of National Academy of Sciences, USA, 93, 3294–3296.
   PubMed Web of Science ®Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• LUCH, A., CONG, S. L., TANG, Y. M., SCHNEIDER, A., SOBALLA, V., GREIM, H., JEFcoATE, C. R., SEIDEL, A., GREENLEE, W. F., BAIRD, W. M. and DOEHMER, J., 1998, Stable expression of human cytochrome P4501B1 in V79 Chinese hamster cells and metabolically catalysed DNA adduct formation of dibenzo[a, /[pyrene. Chemical Research in Toxicology, 11, 686–695.
   PubMed Web of Science ®Google Scholar
• MCLELLAN, R. A., OSCARSON, M., HIDOESTRAND, M., LEIDVIK, B., JoNssoN, E., OTTER, C. and INGELMAN-SUNDBERG, M., 2000, Characterization and functional analysis of two common human cytochrome P4501B1 variants. Archives of Biochemistry and Biophysics, 378, 175–181.
   Google Scholar
• NEBERT, D. W., NELSON, D. R. and FEYEREISEN, R., 1989, Evolution of the cytochrome P450 genes. Xenobiotica, 19, 1149–1160.
   PubMed Web of Science ®Google Scholar
• NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, O., OKUDA, K. and NEBERT, D. W., 1993, The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature. DNA and Cell Biology, 12, 1–51.
   PubMed Web of Science ®Google Scholar
• NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN, J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, O., COON, M. J., ESTABROOK, R. W., GUNSALUS, I. C. and NEBERT, D. W., 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
   PubMedGoogle Scholar
• NOSHIRO, M. and OMURA, T., 1978, Immunochemical study on the electron pathway from NADH to cytochrome P-450 of liver microsomes. Journal of Biochemistry, 83, 61–77.
   PubMed Web of Science ®Google Scholar
• OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
   PubMed Web of Science ®Google Scholar
• OSCARSON et al., n.d. [http://www.imrn.ki.se/CYPalleles].
   Google Scholar
• PARIKH, A., GILLAM, E. M. J. and GUENGERICH, F. P., 1997, Drug metabolism by Escherichia coli expressing human cytochromes P450. Nature Biotechnology, 15, 784–788.
   Google Scholar
• PELKONEN, O. and NEBERT, D. W., 1982, Metabolism of polycyclic aromatic hydrocarbons: Etiologic role in carcinogenesis. Pharmacological Reviews, 34, 189–222.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., GILLAM, E. M. J., ODA, Y., TSUMURA, F., SUTTER, T. R., GUENGERICH, F. P. and INouE, K., 1999a, Metabolism of benzo[a[pyrene to trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by recombinant human cytochrome P4501B1 and purified liver epoxide hydrolase. Chemical Research in Toxicology, 12, 623–629.
   Google Scholar
• SHIMADA, T., HAYES, C. L., YAMAZAKI, H., AMIN, S., HECHT, S. S., GUENGERICH, F. P. and SUTTER, T. R., 1996, Activation of chemically diverse procarcinogens by human cytochrome P4501B1. Cancer Research, 56, 2979–2984.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., TSUMURA, F., GILLAM, E. M. J., GUENGERICH, F. P. and INouE, K., 2000, Role of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cytochrome P4501B1 variants in Escherichia coli. Protein Expression and Purification, 20, 73–80.
   Google Scholar
• SHIMADA, T., WATANABE, J., KAWAJIRI, K., SUTTER, T. R., GUENGERICH, F. P., GILLAM, E. M. J. and INouE, K., 1999b, Catalytic properties of polymorphic human cytochrome P4501B1 variants. Carcinogenesis, 20, 1607–1613.
   Google Scholar
• SHIMADA, T., WUNSCH, R. M., HANNA, I. H., SUTTER, T. R., GUENGERICH, F. P. and GILLAM, E. M. J., 1998a, Recombinant human cytochrome P4501B1 expression in Escherichia coli. Archives of Biochemistry and Biophysics, 357, 111–120.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., YAMAZAKI, H., FOROOZESH, M., HOPKINS, N. E., ALWORTH, W. L. and GUENGERICH, F. P., 1998b, Selectivity of polycyclic inhibitors for human cytochromes P450 1A1, 1A2 and 1B1. Chemical Research in Toxicology, 11, 1048–1056.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• SHIMIZU, Y., NAKATSURU, Y., ICHINOSE, M., TAKAHASHI, Y., KUME, H., MIMURA, J., FUJII-KURIYAMA, Y. and IsmicAwA, T., 2000b, Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proceedings of National Academy of Sciences, USA, 97, 779–782.
   Google Scholar
• SPINK, D. C., EUGSTER, H. P., LINCOLN II, D. W., SCHUETZ, J. D., SCHUETZ, E. G., JouNsoN, J. A., KAMINSKY, L. S. and GIERTHY, J. F., 1992, 17[3-0estradiol hydroxylation catalysed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Archives of Biochemistry and Biophysics, 293, 342–348.
   PubMed Web of Science ®Google Scholar
• SPINK, D. C., SPINK, B. C., CAO, J. Q., GIERTHY, J. F., HAYES, C. L., Li, Y. and SUTTER, T. R., 1997, Induction of cytochrome P4501B1 and catechol oestrogen metabolism in ACHN human renal adenocarcinoma cells. Journal of Steroid and Biochemical Molecular Biology, 62, 223–232.
   PubMed Web of Science ®Google Scholar
• STOILOV, I., AKARSU, A. N., ALOZIE, I., CHILD, A., BARSOUM-HOMSY, M., TURACLI, M. E., OR, M., LEWIS, R. A., OZDEMIR, N., BRICE, G., AKTAN, S. G., CHEVRETTE, L., COCA-PRADOS, M. and SARFARAZI, M., 1998, Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. American Journal of Human Genetics, 62, 573–584.
   Google Scholar
• TANIGUCHI, H., Imm, Y., IYANAGI, T. and SATO, R., 1979, Interaction between NADPH-cytochrome P-450 reductase and cytochrome P-450 in the membrane of phosphatidylcholine vesicles. Biochimica et Biophysica Acta, 550, 341–356.
   PubMed Web of Science ®Google Scholar
• WATANABE, J., SHIMADA, T., GILLAM, E. M. J., IKUTA, T., SUEMASU, K., HIGASHI, Y., GOTOH, O. and KAWAJIRI, K., 2000, Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics, 10, 25–33.
   Google Scholar
• WILLIAMS, C. H., JR. and KAMIN, H., 1962, Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. Journal of Biological Chemistry, 237, 587–595.
   Google Scholar
• YAMAZAKI, H., SHAW, P. M., GUENGERICH, F. P. and SHIMADA, T., 1998, Roles of cytochrome P450 1A2 and 3A4 in the oxidation of oestradiol and oestrone in human liver microsomes. Chemical Research in Toxicology, 11, 659–665.
   PubMed Web of Science ®Google Scholar
• YASUKOCHI, Y. and MASTERS, B. S. S., 1976, Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. Journal of Biological Chemistry, 251, 5337–5344.
   PubMed Web of Science ®Google Scholar